Glaucoma Progression.

Slides:



Advertisements
Similar presentations
RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.
Advertisements

How Do I Know My Glaucoma Treatment is Working? Dr Catherine Green Head: Glaucoma Unit RVEEH.
CDK 4 and 6 Inhibitors in HR-Positive Advanced Breast Cancer: Assessing New Data.
Case-Based Examination of Treatment Options in Type 2 Diabetes Management.
From: The Effects of Study Design and Spectrum Bias on the Evaluation of Diagnostic Accuracy of Confocal Scanning Laser Ophthalmoscopy in Glaucoma Invest.
Glaucoma.
nAMD: Choosing the Best Treatment for your Patient
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
An Update on Oral Prostanoids: Advancing Care for PAH?
Case 53-year-old Black Man
Identifying and Managing Dyspnea Associated With CTEPH
MANAGING GLAUCOMA:.
Motor Fluctuations in Parkinson Disease: Options and Strategies
Modern Strategies for Basal Insulin Use in T2D
Program Goals. Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin.
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Optimizing Outcomes in the Management of GIST
Clinical Cases in Glaucoma Treatment
Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.
Innovative Insulin Combinations: A New strategy for the Person With T2DM.
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Hypertension Guidelines
Challenges in Managing Progressive Multiple Sclerosis
CDK 4 and 6 Inhibitors in HR-Positive Advanced Breast Cancer: Assessing New Data.
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Talking to Patients About Diabetes Management
Clinical Updates in RA: New Developments and Insights From Washington
Best Practices in Metastatic Colorectal Cancer
Moving Prostate Cancer Care Forward: Putting Lessons From New Orleans and Chicago Into Practice.
Glaucoma: Detect, Diagnose, And Monitor The Silent Thief of Vision
From Symptom Management to Communication in Advanced GI Cancers
Delivering Care Closer to Home
Consensus on Glaucoma Control
2013 World Symposium on PH CTEPH Diagnosisa 2013 World Symposium on PH (cont) CTEPH Treatmenta.
Poor Response to Initial Therapy for Migraine
Advancing the Treatment of IBD With Biologics
Hyperkalemia in the Hospital
Vogt-Koyanagi Harada Disease
Key Questions for nAMD Treatment Success
Navigating Treatment Options in PAH
Program Goals Overview Is NEDA a Reasonable Target?
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Maintenance Therapy in Advanced Ovarian Cancer
The Road to Quality Improvement in HER2-Positive Breast Cancer
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
nAMD: Choosing the Best Treatment for your Patient
Program Goals Disclaimers Defining Refractory Seizures.
The Changing Field of Melanoma: Ipilimumab.
Are We Making Progress in the Management of Huntington Disease?
COMBINATIONS AND COFORMULATIONS: THE FUTURE OF INSULIN THERAPY?
خدا نام به.
Incorporating Prostacyclins Into Practice
Challenges in LA SCCHN.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Patient Stories in PAH: Sequential Therapy in a FC II Patient
Program Goal. Program Goal Disclaimer Overview.
Program Goals Overview Is NEDA a Reasonable Target?
Prostacyclin Pathway Agents in Action
خدا نام به.
Issues in Patients With Severe Epilepsy
AMD Therapy: Where Are We Now and Where Are We Going?
The Nurse View: Spotlight on EGFR-Mutated NSCLC
Real-World Evidence.
Fixed-Ratio Combination Therapy in T2DM
The Real Burden of Rosacea
Updates in Best Practices in Non-Small Cell Lung Cancer
Fresh perspectives ON BASAL Insulins in diabetes care
What's New in NOACs in AF?.
Motor Fluctuations in PD
Presentation transcript:

Glaucoma Progression

Program Overview

Patient Case 1: Profile

Optic Nerve Examination

Visual Field Test

Visual Field 10-Year History

Case Review

Treatment: Next Steps

Discussion of Compliance to Current Treatment

Surgical Options

Fluctuations in IOP

Fluctuations in IOP (cont)

Surgical Options (cont)

Patient Follow Up

Patient Case 1: Take Home Messages

Patient Case 2: Profile

Visual Field Test OD

Visual Field Test OS

OCT (October 2015)

Optic Nerve Examination

Case Review and Next Steps

Fixed Dose Combinations

Progression in Only One Eye

Patient Case 2: Treatment and Follow Up

Other Issues in Glaucoma Therapy

Patient Case 2: Take Home Messages

Summary

Abbreviations

Abbreviations (cont)